Luolifen Holdings Co., Ltd. 2025 Q4 Financials
NQ Score
55/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Luolifen Holdings Co., Ltd. (Company Code: 6666), operating in the Biotechnology and Medical Industry, announced its Q4 2025 financial results. The company reported a basic earnings per share of NTD 2.42, with operating revenue reaching NTD 1.113 billion and net income after tax at NTD 108 million.
AI analysis data is not yet available.